THE SIDE-EFFECTS OF ANTIPSYCHOTIC DRUGS. I. CNS AND NEUROMUSCULAR EFFECTS

[1]  P. Sachdev.  Tardive and chronically recurrent oculogyric crises , 1993, Movement disorders : official journal of the Movement Disorder Society.

[2]  J. Kornhuber,et al.  Clozapine Rechallenge after an Episode of ‘Neuroleptic Malignant Syndrome’ , 1992, British Journal of Psychiatry.

[3]  T. Barnes,et al.  Relationship Between Iron Status and Chronic Akathisia in an In-patient Population with Chronic Schizophrenia , 1992, British Journal of Psychiatry.

[4]  R. P. Gregory,et al.  Tardive dyskinesia presenting as severe dysphagia. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[5]  T. White,et al.  Sub-syndromes of tardive dyskinesia and some clinical correlates , 1992, Psychological Medicine.

[6]  R. Yassa,et al.  Tardive dyskinesia in elderly psychiatric patients: a 5-year study. , 1992, The American journal of psychiatry.

[7]  H. Hermesh,et al.  Risk for Definite Neuroleptic Malignant Syndrome , 1992, British Journal of Psychiatry.

[8]  S. Schulz,et al.  Akathisia: clinical phenomenology and relationship to tardive dyskinesia. , 1992, Comprehensive psychiatry.

[9]  G. Sedvall,et al.  Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. , 1992, Archives of general psychiatry.

[10]  T. Barnes,et al.  Is the Concept of Frontal–Subcortical Dementia Relevant to Schizophrenia? , 1992, British Journal of Psychiatry.

[11]  P. Bannister,et al.  Missed neuroleptic malignant syndrome. , 1992, BMJ.

[12]  T. Barnes.  Clinical assessment of the extrapyramidal side effects of antipsychotic drugs , 1992, Journal of psychopharmacology.

[13]  J. Sweeney,et al.  Increased tardive dyskinesia in alcohol-abusing schizophrenic patients. , 1992, Comprehensive psychiatry.

[14]  C. Pantelis,et al.  Alcohol use in schizophrenia: Symptomatology, relationship with tardive dyskinesia and age at onset , 1992, Schizophrenia Research.

[15]  G. Reynolds,et al.  Dopamine D2 receptor changes in the pallidum: Their relationship with antipsychotic drug treatment and dyskinesias in schizophrenia , 1992, Schizophrenia Research.

[16]  R. Macpherson,et al.  Tardive Dyskinesia , 1992, British Journal of Psychiatry.

[17]  D. Jeste,et al.  Gender differences in tardive dyskinesia: a critical review of the literature. , 1992, Schizophrenia bulletin.

[18]  D. Jeste,et al.  High incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics. , 1992, Psychopharmacology bulletin.

[19]  L. Miller,et al.  Persistent dystonia possibly induced by flecainide , 1992, Movement disorders : official journal of the Movement Disorder Society.

[20]  J. Lieberman,et al.  Prospective study of tardive dyskinesia incidence in the elderly. , 1991, JAMA.

[21]  J. Horiguchi,et al.  Low serum iron in patients with neuroleptic‐induced akathisia and dystonia under antipsychotic drug treatment , 1991, Acta psychiatrica Scandinavica.

[22]  J. Wojcik,et al.  A review of 32 cases of tardive dystonia. , 1991, The American journal of psychiatry.

[23]  S. Sagar.  Neuroleptic Malignant Syndrome: A Diagnostic Dilemma , 1991, Journal of the Royal Society of Medicine.

[24]  P. Keck,et al.  Declining frequency of neuroleptic malignant syndrome in a hospital population. , 1991, The American journal of psychiatry.

[25]  T. White,et al.  Pseudoakathisia and negative symptoms in schizophrenic subjects , 1991, Acta psychiatrica Scandinavica.

[26]  B. Cohen,et al.  Prevalence and severity of akathisia in patients on clozapine , 1991, Biological Psychiatry.

[27]  P. Keck,et al.  Neuroleptic malignant syndrome: long-term follow-up of 20 cases. , 1991, The Journal of clinical psychiatry.

[28]  Klaus P. Ebmeier,et al.  Serum iron and transferrin in acute neuroleptic induced akathisia. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[29]  J. Gerlach.  Current views on tardive dyskinesia. , 1991, Pharmacopsychiatry.

[30]  R. Schoentag,et al.  Serum iron levels and akathisia , 1991, Biological Psychiatry.

[31]  J. Guimón,et al.  Evidence of low dopaminergic activity in elderly women with spontaneous orofacial dyskinesia , 1991, Acta psychiatrica Scandinavica.

[32]  D. King.  The Effect of Neuroleptics on Cognitive and Psychomotor Function , 1990, British Journal of Psychiatry.

[33]  J. Waddington,et al.  Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia , 1990, Psychological Medicine.

[34]  S. Marder,et al.  A controlled dose comparison of haloperidol in newly admitted schizophrenic patients. , 1990, Archives of general psychiatry.

[35]  Klaus P. Ebmeier,et al.  Low plasma iron status and akathisia. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[36]  G. Gardos,et al.  Tardive dyskinesia: Outcome at 10 years , 1990, Schizophrenia Research.

[37]  T. Barnes.  Movement Disorder Associated with Antipsychotic Drugs: The Tardive Syndromes , 1990 .

[38]  A. Gelenberg,et al.  Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients. , 1989, The Journal of clinical psychiatry.

[39]  J. Corwin,et al.  Pharmacologic challenge in akathisia variants , 1989, Schizophrenia Research.

[40]  J. Waddington.  Schizophrenia, affective psychoses, and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants, and the conflict of paradigms. , 1989, International review of neurobiology.

[41]  H. Pope,et al.  Fluoxetine-induced akathisia: clinical and theoretical implications. , 1989, The Journal of clinical psychiatry.

[42]  S. Fahn,et al.  Tardive akathisia: An analysis of clinical features and response to open therapeutic trials , 1989, Movement disorders : official journal of the Movement Disorder Society.

[43]  P. Keck,et al.  Beta-adrenergic antagonists in psychosis: is improvement due to treatment of neuroleptic-induced akathisia? , 1988, Journal of clinical psychopharmacology.

[44]  Dufresne Rl,et al.  Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia. , 1988 .

[45]  D. Weinberger.  Neurodevelopmental Model of Schizophrenia-Reply , 1988 .

[46]  R. Murray,et al.  Neurodevelopmental Model of Schizophrenia , 1988 .

[47]  J. Sramek,et al.  High Potency Neuroleptics and Violence in Schizophrenics , 1988, The Journal of nervous and mental disease.

[48]  G. Gardos,et al.  The natural history of tardive dyskinesia. , 1988, Journal of clinical psychopharmacology.

[49]  R. Yassa,et al.  Propranolol in the treatment of tardive akathisia: a report of two cases. , 1988, Journal of clinical psychopharmacology.

[50]  G. Alexopoulos,et al.  Drug-induced dystonia in young and elderly patients. , 1988, The American journal of psychiatry.

[51]  J. J. Ryan,et al.  Cognitive Sequelae of Tardive Dyskinesia , 1988, The Journal of nervous and mental disease.

[52]  J. Leff,et al.  The clinical course of depressive symptoms in schizophrenia , 1988, Schizophrenia Research.

[53]  B. Pfohl,et al.  The relationship of haloperidol concentrations to therapeutic response. , 1988, Journal of clinical psychopharmacology.

[54]  S. Caroff,et al.  Neuroleptic malignant syndrome , 1980, Psychopharmacology bulletin.

[55]  Martin H. Teicher,et al.  Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. , 1988, Archives of general psychiatry.

[56]  J. Cummings,et al.  Tardive dystonia: clinical spectrum and novel manifestations. , 1988, Behavioural neurology.

[57]  F. Abuzzahab,et al.  The Risks and Benefits of Clozapine versus Chlorpromazine , 1987, Journal of clinical psychopharmacology.

[58]  A. House,et al.  Depressive Syndromes in the Year following Onset of a First Schizophrenic Illness , 1987, British Journal of Psychiatry.

[59]  T. White,et al.  PATHOPHYSIOLOGY OF AKATHISIA , 1987, The Lancet.

[60]  G. Yagi,et al.  Follow-up study of 11 patients with potentially reversible tardive dyskinesia. , 1987, The American journal of psychiatry.

[61]  J. Waddington,et al.  Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality. , 1987, Archives of general psychiatry.

[62]  S. Roth,et al.  Neuroleptic malignant syndrome: review and analysis of 115 cases , 1987, Biological Psychiatry.

[63]  B. Cohen,et al.  Antidepressant-related akathisia. , 1987, Journal of clinical psychopharmacology.

[64]  C. Tamminga,et al.  Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment. , 1987, Archives of general psychiatry.

[65]  A. Kellam,et al.  The Neuroleptic Malignant Syndrome, So-called , 1987, British Journal of Psychiatry.

[66]  T. White,et al.  LOW SERUM IRON STATUS AND AKATHISIA , 1987, The Lancet.

[67]  J. Waddington,et al.  Tardive dyskinesia in schizophrenia and other disorders: Associations with ageing, cognitive dysfunction and structural brain pathology in relation to neuroleptic exposure , 1987 .

[68]  J. Wade,et al.  Tardive dyskinesia and cognitive impairment , 1987, Biological Psychiatry.

[69]  H. Youssef,et al.  Morbidity and mortality in tardive dyskinesia: associations in chronic schizophrenia , 1987, Acta psychiatrica Scandinavica.

[70]  P. Weiden,et al.  Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study. , 1987, American Journal of Psychiatry.

[71]  P. Keck,et al.  Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. , 1986, The American journal of psychiatry.

[72]  S. Marder,et al.  Toward a more reliable diagnosis of akathisia. , 1986, Archives of general psychiatry.

[73]  M. Munetz.  Akathisia variants and tardive dyskinesia. , 1986, Archives of general psychiatry.

[74]  W. Gibb,et al.  The clinical phenomenon of akathisia. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[75]  R. Yassa,et al.  Prevalence of tardive dystonia , 1986, Acta psychiatrica Scandinavica.

[76]  H. Pall,et al.  Iron and akathisia. , 1986, British medical journal.

[77]  R. Yassa,et al.  Respiratory irregularity and tardive dyskinesia A prevalence study , 1986, Acta psychiatrica Scandinavica.

[78]  A. Rosen,et al.  Persistent tardive dyskinesia in bipolar patients. , 1986, Archives of general psychiatry.

[79]  A. Shalev,et al.  The neuroleptic malignant syndrome: agent and host interaction , 1986, Acta psychiatrica Scandinavica.

[80]  J. Pope.  Practical Comprehensive Treatment of Anorexia Nervosa and Bulimia , 1986 .

[81]  A. Roy.  Depression, attempted suicide, and suicide in patients with chronic schizophrenia. , 1986, The Psychiatric clinics of North America.

[82]  S. Dahl.  Plasma Level Monitoring of Antipsychotic Drugs Clinical Utility , 1986, Clinical pharmacokinetics.

[83]  G. Chouinard,et al.  A five year follow-up study of tardive dyskinesia. , 1986, Psychopharmacology bulletin.

[84]  R. Burke,et al.  Natural history and treatment of tardive dystonia , 1986, Movement disorders : official journal of the Movement Disorder Society.

[85]  J. Lieberman,et al.  Integrating incidence and prevalence of tardive dyskinesia. , 1986, Psychopharmacology bulletin.

[86]  D. Ben-shachar,et al.  Effect of Iron Chelators on Dopamine D2 Receptors , 1985, Journal of neurochemistry.

[87]  D. Rogers.  The Motor Disorders of Severe Psychiatric Illness: A Conflict of Paradigms , 1985, British Journal of Psychiatry.

[88]  M. Raskind,et al.  Iron pigment in the brain of a man with tardive dyskinesia. , 1985, The American journal of psychiatry.

[89]  R. Yassa.  The Pisa Syndrome: A Report of Two Cases , 1985, British Journal of Psychiatry.

[90]  S. Channabasavanna,et al.  Is akathisia a forerunner of tardive dyskinesia? A clinical report with brief review of literature , 1984, Clinical Neurology and Neurosurgery.

[91]  B. Jones,et al.  Withdrawal symptoms after long-term treatment with low-potency neuroleptics. , 1984, The Journal of clinical psychiatry.

[92]  A. Eppel,et al.  The Mechanism of Neuroleptic Withdrawal * , 1984, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[93]  F. Struve,et al.  Cognitive Dysfunction and Tardive Dyskinesia , 1983, British Journal of Psychiatry.

[94]  S. Gore,et al.  Clinical Characteristics of Akathisia , 1983, British Journal of Psychiatry.

[95]  Braude Wm,et al.  Late-onset akathisia--an indicant of covert dyskinesia: two case reports. , 1983 .

[96]  G. Gardos,et al.  The prognosis of tardive dyskinesia. , 1983, The Journal of clinical psychiatry.

[97]  J. Glezos,et al.  Drug-induced heat stroke , 1983, Canadian Medical Association journal.

[98]  W. Weiner,et al.  Persistent akathisia following neuroleptic withdrawal , 1983, Annals of neurology.

[99]  T. Barnes,et al.  Tardive dyskinesia: a 3-year follow-up study , 1983, Psychological Medicine.

[100]  C. Marsden,et al.  Tardive dystonia , 1982, Neurology.

[101]  K. Davis,et al.  The Neuropharmacology of Tardive Dyskinesia, Spontaneous Dyskinesia, and Other Dystonias , 1982, Journal of clinical psychopharmacology.

[102]  J. Kane,et al.  A Prospective Study of Tardive Dyskinesia Development: Preliminary Results , 1982, Journal of clinical psychopharmacology.

[103]  M. Trimble,et al.  Major tranquillisers used as antidepressants. A review. , 1982, Journal of affective disorders.

[104]  M. Munetz,et al.  Akathisia, pseudoakathisia and tardive dyskinesia: clinical examples. , 1982, Comprehensive psychiatry.

[105]  T. S. Jones,et al.  Risk factors for heatstroke. A case-control study. , 1982, JAMA.

[106]  J. Kane,et al.  Research diagnoses for tardive dyskinesia. , 1982, Archives of general psychiatry.

[107]  J. Kane,et al.  Tardive dyskinesia: prevalence and risk factors, 1959 to 1979 , 1982, Archives of general psychiatry.

[108]  M. Alpert,et al.  Depression as a risk factor in tardive dyskinesia. , 1982, Biological psychiatry.

[109]  G. Gardos,et al.  Adverse effects of antiparkinson drug withdrawal. , 1981, The American journal of psychiatry.

[110]  J. Modestin,et al.  A fatality during haloperidol treatment: mechanism of sudden death. , 1981, The American journal of psychiatry.

[111]  C. Golden,et al.  Effects of long-term neuroleptic use on brain density , 1981, Psychiatry Research.

[112]  D. A. Johnson,et al.  Studies of Depressive Symptoms in Schizophrenia , 1981, British Journal of Psychiatry.

[113]  S. Hirsch,et al.  "Revealed" Depression and drug treatment for schizophrenia. , 1981, Archives of general psychiatry.

[114]  M. Gresty,et al.  Tremor, the cogwheel phenomenon and clonus in Parkinson's disease. , 1981, Journal of neurology, neurosurgery, and psychiatry.

[115]  K. Abe,et al.  Age-Sex Trends of Phobic and Anxiety Symptoms in Adolescents , 1981, British Journal of Psychiatry.

[116]  D. Jeste,et al.  Changing epidemiology of tardive dyskinesia: an overview. , 1981, American Journal of Psychiatry.

[117]  R. Baldessarini,et al.  Changes in prevalence, severity, and recovery in tardive dyskinesia with age. , 1980, Archives of general psychiatry.

[118]  T. Barnes,et al.  Sub-syndromes of tardive dyskinesia , 1980, Psychological Medicine.

[119]  C. Carter,et al.  Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats , 1980, Nature.

[120]  E. Silbergeld,et al.  Estrogen treatment enhances dopamine receptor sensitivity in the rat striatum. , 1980, European journal of pharmacology.

[121]  C. Marsden,et al.  The pathophysiology of extrapyramidal side-effects of neuroleptic drugs , 1980, Psychological Medicine.

[122]  T. Crow,et al.  Molecular pathology of schizophrenia: more than one disease process? , 1980, British medical journal.

[123]  Haas Jf,et al.  Prevalence of tardive dyskinesia. , 1979 .

[124]  O. Famuyiwa,et al.  Tardive Dyskinesia and Dementia , 1979, British Journal of Psychiatry.

[125]  Smith Jm,et al.  Sex differences in the prevalence of severe tardive dyskinesia. , 1979 .

[126]  R. A. Cooper.  Heat and neuroleptics: a deadly combination. , 1979, The American journal of psychiatry.

[127]  Remick Ra,et al.  Antipsychotic drugs and seizures. , 1979 .

[128]  A. Jus,et al.  Long term treatment of tardive dyskinesia. , 1979, The Journal of clinical psychiatry.

[129]  G. Chouinard,et al.  Factors related to tardive dyskinesia. , 1979, The American journal of psychiatry.

[130]  Flaherty Ja,et al.  Laryngeal-pharyngeal dystonia as a possible cause of asphyxia with haloperidol treatment. , 1978 .

[131]  D. Tarsy,et al.  Withdrawal syndromes associated with antipsychotic drugs. , 1978, The American journal of psychiatry.

[132]  T. Putten,et al.  "Akinetic depression" in schizophrenia. , 1978, Archives of general psychiatry.

[133]  W. P. Boger,et al.  Psychotropic drugs, summer heat and humidity, and hyperpyrexia: a danger restated. , 1978, The American journal of psychiatry.

[134]  J. Glowinski,et al.  Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the frontocortical dopaminergic innervation in the rat , 1978, Brain Research.

[135]  D. Mehta,et al.  Tardive Dyskinesia in Psychogeriatric Patients: A Five‐Year Follow‐Up , 1977, Journal of the American Geriatrics Society.

[136]  J. Frost,et al.  Clinical research techniques in tardive dyskinesia. , 1977, The American journal of psychiatry.

[137]  S. Shapiro,et al.  Hypotension due to chlorpromazine. Relation to cigarette smoking, blood pressure, and dosage. , 1977, Archives of general psychiatry.

[138]  G. Fenton,et al.  Epileptic seizures induced by psychotropic drugs , 1977, Psychological Medicine.

[139]  H. Mcclelland.  Assessment of drugs in schizophrenia. Discussion on assessment of drug-induced extrapyramidal reactions. , 1976, British journal of clinical pharmacology.

[140]  M. Critchley.  Drug Treatment of Parkinsonism , 1958, The New Zealand medical journal.

[141]  Donald C. M. Smith.  Dr. Smith Replies , 1975 .

[142]  F. Quitkin,et al.  Akinesia: A Poorly Recognized Drug-Induced Extrapyramidal Behavioral Disorder , 1975 .

[143]  T. Putten.  The many faces of akathisia. , 1975 .

[144]  M. Carney,et al.  Forty-Two Months Experience of Flupenthixol Decanoate in the Maintenance Treatment of Schizophrenia , 1975 .

[145]  C. Swett.  Drowsiness due to chlorpromazine in relation to cigarette smoking. A report from the Boston Collaborative Drug Surveillance Program. , 1974, Archives of general psychiatry.

[146]  T. Putten.  Why do schizophrenic patients refuse to take their drugs , 1974 .

[147]  H. Klawans.  The pharmacology of tardive dyskinesias. , 1973, The American journal of psychiatry.

[148]  A. Smith,et al.  Perphenazine side-effects presenting in oral surgical practice. , 1973, The British journal of oral surgery.

[149]  G. Crane.  Pseudoparkinsonism and tardive dyskinesia. , 1972, Archives of neurology.

[150]  H. Kazamatsuri,et al.  Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine. , 1972, Archives of general psychiatry.

[151]  J. Crammer,et al.  Benzhexol and Side Effects with Long-acting Fluphenazine Therapy , 1972, British medical journal.

[152]  P. Yarden,et al.  Abnormal movements and prognosis in schizophrenia. , 1971, The American journal of psychiatry.

[153]  S. Iversen.  The effect of surgical lesions to frontal cortex and substantia nigra on amphetamine responses in rats. , 1971, Brain research.

[154]  C. S. Alexander,et al.  Cardiovascular complications in young patients taking psychotropic drugs. A preliminary report. , 1969, American heart journal.

[155]  M. Carney,et al.  Severe Depressive Mood Changes Following Slow-release Intramuscular Fluphenazine Injection , 1969, British medical journal.

[156]  M. Fink.  EEG and human psychopharmacology. , 1969, Annual review of pharmacology.

[157]  J. Cumings,et al.  Neuropathological findings in three cases of persistent dyskinesia following phenothiazine medication. , 1968, Journal of the neurological sciences.

[158]  J. Logothetis.  Spontaneous epileptic seizures and electroencephalographic changes in the course of phenothiazine therapy , 1967, Neurology.

[159]  T. Meade,et al.  HYPOTHERMIA FOLLOWING CHLORPROMAZINE THERAPY IN MYXOEDEMATOUS PATIENTS. , 1964, Gerontologia clinica.

[160]  R. J. Johns,et al.  Chlorpromazine-induced weakness in myasthenia gravis. , 1963, Archives of neurology.

[161]  P. Lund-johansen.  Shock after administration of phenothiazines in patients with pheochromocytoma. , 2009, Acta medica Scandinavica.

[162]  K. Ekbom,et al.  Comparison between akathisia developing on treatment with phenothiazine derivatives and the restless legs syndrome. , 2009, Acta medica Scandinavica.

[163]  F. Ayd.  A survey of drug-induced extrapyramidal reactions. , 1961, JAMA.

[164]  K. Ekbom.  Restless legs syndrome , 1960, Neurology.

[165]  W. Kruse.  Persistent muscular restlessness after phenothiazine treatment: report of 3 cases. , 1960, The American journal of psychiatry.

[166]  J. Delay.  Un neuroleptique majeur non phenotiadine et non reserpinique, haloperidol, dans le traitement des psychoses , 1960 .

[167]  I. Brody.  Shock after administration of prochlorperazine in patient with pheochromocytoma; report of a case with spontaneous tumor destruction. , 1959, Journal of the American Medical Association.

[168]  A. R. May,et al.  Use and Action of Chlorpromazine in Psychoneuroses , 1954, British medical journal.